Cross‐national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys

Abstract

Aims To examine cross-national patterns of 12-month substance use disorder (SUD) treatment and minimally adequate treatment (MAT), and associations with mental disorder comorbidity. Design Cross-sectional, representative household surveys. Setting Twenty-seven surveys from 25 countries of the WHO World Mental Health Survey Initiative. Participants A total of 2446 people with past-year DSM-IV SUD diagnoses (alcohol or illicit drug abuse and dependence). Measurements Outcomes were SUD treatment, defined as having either received professional treatment or attended a self-help group for substance-related problems in the past 12 months, and MAT, defined as having either four or more SUD treatment visits to a health-care professional, six or more visits to a non-health-care professional or being in ongoing treatment at the time of interview. Covariates were mental disorder comorbidity and several socioeconomic characteristics. Pooled estimates reflect country sample sizes rather than population sizes. Findings Of respondents with pastyear SUD, 11.0% [standard error (SE) = 0.8] received past 12-month SUD treatment. SUD treatment was more common among people with comorbid mental disorders than with pure SUDs (18.1%, SE = 1.6 versus 6.8%, SE = 0.7), as was MAT (84.0%, SE = 2.5 versus 68.3%, SE = 3.8) and treatment by health-care professionals (88.9%, SE = 1.9 versus 78.8%, SE = 3.0) among treated SUD cases. Adjusting for socioeconomic characteristics, mental disorder comorbidity doubled the odds of SUD treatment [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.71-3.20], MAT among SUD cases (OR = 2.75; 95% CI = 1.90-3.97) and MAT among treated cases (OR = 2.48; 95% CI = 1.23-5.02). Patterns were similar within country income groups, although the proportions receiving SUD treatment and MAT were higher in highthan low-/middle-income countries. Conclusions Few people with past-year substance use disorders receive adequate 12-month substance use disorder treatment, even when comorbid with a mental disorder. This is largely due to the low proportion of people receiving any substance use disorder treatment, as the proportion of patients whose treatment is at least minimally adequate is high.

Abuse and misuse of second‐generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database

“…Quetiapine and olanzapine were also associated with the use of illicit substances (mainly heroin and cocaine), possibly to enhance and/or counteract the remaining effects or to limit withdrawal symptoms 9 . The consumption of psychoactive substances in patients taking psychotropic drugs can be part of a dual pathology (addictive disorder and at least 1 other mental health disorder) 27 . Such patients require an integrated treatment plan to manage both disorders as interconnected mental health issues.…”

Inflammation levels in patients with alcohol and substance use disorders

“…Alkol/Madde Kullanım Bozukluğu (AMKB); alınan tüm önlemlere rağmen önemli bir halk sağlığı sorunu olmaya devam etmektedir. Her yıl dünya nüfusunun ortalama %2,6'sının AMKB'dan etkilendiği gösterilmiştir 1,2 . Dünya Sağlık Örgütü (DSÖ) 2008 yılı verilerine göre küresel olarak 52,3 milyon alkol/yasa dışı madde kullanımı ve kullanım bozukluğu hastası rapor edilmiştir 3 .…”

Effectiveness of online training for improving knowledge, attitudes, and confidence of alcohol and other drug workers in relation to co-occurring mental health conditions

“…Workforce capacity to address co-occurring mental and substance use conditions is an international concern. In 2019, an estimated one-in-three, or 36.9% of people worldwide with a substance use disorder experienced at least one co-occurring mental disorder (Harris et al, 2019), yet treatment need remains high. Of particular concern, more than half (51.4%) of US adults who experienced co-occurring mental and substance use disorders did not receive substance use or mental health services (Substance Abuse and Mental Health Services Administration, 2020).…”